Premature Ejaculation Treatment
|
|||
|
Click Here For A Premature Ejaculation Treatment That Works Latest developments for men who climax too rapidly.Sciele Pharma Inc. announced in July 2009 that another double-blind, placebo-controlled study of their new compound PSD502, designed for for the treatment of rapid or premature ejaculation has fulfilled all the measures needed to regard it as a successful treatment. These measures include standards of Intravginal Ejaculatory Latency Time and the International Index of Sexual Satisfaction. The latest study, whose precursor is reported elsewhere, was conducted on men from the USA, Canada and Europe. Previous research had been conducted on men from Europe, and the results reported in November 2008. Final approval for the product will be sought on the basis of the combined data. The President and Chief Operating Officer
of Sciele Pharma, Ed Schutter, reminded us that if the product gets FDA
approval, it will be the first prescription treatment in the United
States specifically designed to deal with the common condition of
premature ejaculation. Both the first and second studies showed consistent results. PSD502 showed highly statistically significant improvements from the start of the study in all measures: intra-vaginal ejaculation latency time (IELT), ejaculatory control, sexual satisfaction, and partner satisfaction. More specifically, IELT improved by a factor of six; the IPE domains for ejaculatory control and sexual satisfaction showed a five point increase; and partner satisfaction increased "considerably". All these results were highly statistically significant. Happily, there were no more serious adverse events and overall side effects in the group of men treated with PSD502 than there were in the placebo group. There were no systemic adverse events, although a small number of men experienced a degree of numbness to the penis. This was less than 3% of the cohort. It seems that PSD502 is going to be of great benefit to both men with rapid ejaculation and their partners: especially since the product can be used on an "on-demand" basis. It only takes five minutes before it becomes effective, and there must be many men who would like the product to be licensed as soon as possible! (Up to 75% of men ejaculate too rapidly for their liking or their partner's sexual satisfaction.) This drug certainly seems to have great promise in field of premature ejaculation treatment. I'd also like to remind you men out there
that not all sexual pleasure is down to a man's capacity to develop
sufficient staying power to last a long time in bed. Pleasing a woman
sexually requires a degree of skill and finesse which goes well beyond
the ability to sustain a high IELT. It's worthwhile checking out this
link for more information on a subset of sexual skills which are
necessary for all men who (1) wish to be competent lovers and (2) have a
desire to know how to please a
woman in bed. We'll let you know if or when this drug gets FDA approval! My own interpretation of comments about PE on The Male Health Centre is as follows: Misconceptions and myths about premature ejaculation include the following:
Causes of PEThere is very little hard and fast medical evidence about the causes of PE. This is one of the reasons why it has proved so difficult to treat. It is reasoning after the event to identify a particular characteristic of men with PE and then infer that this causes PE - this applies to the suggestion that the pelvic muscles, and in particular the muscles around the erectile bodies in the penis, are hyperactive in men who experience premature ejaculation. Ejaculation involves increased activity of these muscle groups; ergo, it seems men who come too soon may have hyperactive muscles already aroused and approaching the threshold of ejaculation. One of the experts at Male Health Center observes that he has been evaluating and treating men with sexual problems including impotence and premature ejaculation for several years, and has observed that men with premature ejaculation show increased sensitivity to vibration in the penis, at least when set alongside men who do not have the problem. He infers that PE may be caused by hypersensitivity of the penis and pelvic muscle hyperspasticity. This idea has not been proved by research. if this is so, however, then a combination of relaxation methods and the anesthetic spray mentioned above must be a combination likely to help a man last longer in bed. In the absence of a licenses for PSD502, we recommend the program on this website and self-hypnosis. Some antidepressants, in particular selective serotonin reuptake inhibitors (SSRIs) such as Prozac, can delay ejaculation or stop it altogether. Since serotonin in the brain is associated with a chain of events which leads to ejaculation, there may be a biochemical link here. However, I'd fundamentally disagree with the writer's observation that the majority of cases of PE are treated pharmaceutically. My own experience has suggested that two things are key in treating PE: first, getting a man into his mature masculine power, so he feels a full awareness of his adult male sexuality, as opposed to the much more common, immature, boyish form of male sexual responsively and sexual pleasure - in other words, dealing with developmental issues around male psychology - and second, training the body to last longer before it ejaculates, which is done with a variety of methods, all of which are described on this very website. Drug therapy As many men who have been given SSRIs for the treatment of depression will know, delayed ejaculation is a common side-effect of antidepressant prescription medications. This has led to their use as medication for a treatment to stop or prevent premature ejaculation. However, perhaps not unexpectedly, not one of them has been approved by the FDA for use in this context: therefore, if prescribed to treat premature ejaculation they are "off label". Attention has centered on Prozac, Zoloft, and Paxil. Early investigations demonstrated that Paxil was the most effective drug at controlling premature ejaculation, sometimes extending the interval between penetration and ejaculation from one minute to ten. However, the side effects can be troublesome, and the drug has to be taken in a calculated way about four hours before intercourse. An alternative is to take the drug daily so that spontaneous sex is still possible, but many men would balk at the idea of taking a drug to treat depression on a regular basis as a method of controlling premature ejaculation. Even more alarmingly
it has been reported that after taking the drug for between one and two
weeks, men can then stop taking it on a daily basis and simply take it
for hours before intercourse is required. This raises the interesting
question of what biochemical changes are taking place in the brain, and
what other effect these may be having on a man's long-term welfare
besides preventing premature ejaculation. Intuitively it does seem
strange when effective therapeutic treatments such as those described on
this website are available that a man would turn to prescription
medication to treat his condition, although one has to recognize the
power of the medical profession at work here. Counseling As you may have
gathered, our own preferred method of treating premature ejaculations
through a psychological approach, which mirrors the processes used in
formal counseling for marital and relationship issues. There is no doubt
that premature ejaculation can offer a very significant problem in
relationships, as well as having a profound effect on the man's
self-esteem and sexual self-confidence. Any treatment method that
approach is premature ejaculation as an isolated condition for the man
himself is worthy of suspicion: the exercises on this website, for
example, all involve the man's partner although the initial stages can
be conducted on his own. More news about developments in premature ejaculation treatment
|
|
||
